On Nov 26, the company announced that it entered into a distribution agreement with Chinese biotech company JOYSBIO for its antigen rapid test kits for Covid-19 (called Colloidal Gold).
In an unrated note published in a question and answer format on Dec 14, PhillipCapital’s research team spoke to Biolidics on the company’s recent developments on its SARS-CoV-2 Antigen Rapid Test Kit and other Covid-19 test kits.
In March 2020, the Singapore-based medical technology company launched its IgC/IgM antibody test kit for Covid-19.
